Cannabis

Medical cannabis dispensary workers such as budtenders, managers and pharmacists often made recommendations on cannabis use to customers based on their personal or coworkers’ experience, according to findings published in JAMA Network Open.

Comprehensive knowledge of the vast array of products is necessary for rheumatologists whose patients desire to use cannabis to treat their condition, according to a presenter at the 2021 Congress of Clinical Rheumatology-West.

An international panel of experts reported that non-inhaled medical cannabis or cannabinoids were associated with modest benefits in patients with chronic pain.

A history of myocardial infarction was more frequently reported among young adults who recently used cannabis compared with those who did not use the substance, a cross-sectional study showed.

The American College of Rheumatology recommended that patients with rheumatic diseases who are on immunosuppressants receive a third dose of an mRNA COVID-19 vaccine. It was the top story in rheumatology last week.

Boys and girls aged 15 to 17 years who used cannabis frequently were six times more likely to have a preterm baby later in life, even if the substance was used prior to conception, a 20-year population cohort study showed.

There is no doubt that patients with rheumatic and autoimmune diseases are taking full advantage of relaxed laws in the United States surrounding recreational cannabis use.

College students had significantly higher alcohol and cannabis use, depressive symptoms and anger during the COVID-19 lockdown compared with before it, according to results of a survey study published in Journal of Psychiatric Research.

Patients with cancer used marijuana less often than the general public despite increased legalization and social acceptance of the drug, according to results of a study published in Cancer.

Data show that cannabis use tripled from 2014 to 2019 among patients with rheumatic disease. Experts said this may be due to patients’ dissatisfaction with their health. A review of the data was the top story in rheumatology last week.